X @Bloomberg
Bloomberg·2025-10-27 22:47
Australian biotech giant CSL has delayed the planned spinoff its Seqirus vaccine business, citing heightened volatility in the US influenza vaccine market https://t.co/M5tZefX6om ...
Australian biotech giant CSL has delayed the planned spinoff its Seqirus vaccine business, citing heightened volatility in the US influenza vaccine market https://t.co/M5tZefX6om ...